CUSIP No. 8676EP108
Amendment No. 7 to Schedule 13D
This Amendment No. 7 (Amendment No. 7) amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the
SEC) on October 17, 2016, as amended by Amendment No. 1 to the Schedule 13D filed on March 8, 2017, as further amended by Amendment No. 2 to the Schedule 13D filed on May 10, 2017, as further amended by Amendment
No. 3 to Schedule 13D filed on May 17, 2017, as further amended by Amendment No. 4 to the Schedule 13D filed on December 15, 2017, as further amended by Amendment No. 5 to the Schedule 13D filed on April 21, 2020, and
as further amended by Amendment No. 6 to the Schedule 13D filed on April 24, 2020 (as amended, the Schedule 13D). Except as set forth herein, the Schedule 13D remains in full force and effect. Each capitalized term used but not
defined herein has the meaning ascribed to such term in the Schedule 13D.
Item 4.
|
Interests in Securities of the Issuer
|
Item 4 of the Schedule 13D is hereby amended and supplemented to add the following:
Ownership percentages set forth in this Amendment No. 7 are based upon a total of 89,403,199 Common Shares of the Issuer issued and outstanding as of
July 31, 2020, as disclosed in the Issuers Quarterly Report on Form 10-Q for the quarterly period ended June 27, 2020, and assumes the exchange of Series A Preferred Stock and Series B-1 Preferred Stock beneficially owned by each Reporting Person, as applicable, into Common Shares (subject in all cases to the Series B-1 Exchange Caps to
which the Oaktree Funds are subject, and described more fully in Item 6 of Amendment 5 to this Schedule 13D).
On March 31, 2020, the Issuer elected
to pay the dividend payable on the Series A Preferred Stock by increasing the Liquidation Preference on each share of outstanding Series A Preferred Stock by the amount of such dividend. As a result, the aggregate Liquidation Preference on the
shares of Series A Preferred Stock held by Organics and OHIF II LP increased by an aggregate of $1,423,920 and $276,080, respectively, and the number of Common Shares issuable upon the exchange of such Series A Preferred Stock increased by an
aggregate of 203,417 and 39,440, respectively.
On June 30, 2020, the Issuer elected to pay the dividend payable on the Series A Preferred Stock and
the Series B-1 Preferred Stock by increasing the respective Liquidation Preference on each share of outstanding Series A Preferred Stock and Series B-1 Preferred Stock
by the respective amount of such dividend. As a result, (i) the aggregate Liquidation Preference on the shares of Series A Preferred Stock held by Organics and OHIF II LP increased by an aggregate of $1,452,398 and $281,602, respectively,
and the number of Common Shares issuable upon the exchange of such Series A Preferred increased by an aggregate of 207,485 and 40,229, respectively, and (ii) the aggregate Liquidation Preference on the shares of Series B-1 Preferred Stock held by Organics and OHIF II LP increased by an aggregate of $186,685 and $36,649, respectively, and, subject to the Series B-1 Exchange Caps to which the
Oaktree Funds are subject, and described more fully in Item 6 of Amendment 5 to this Schedule 13D, the number of Common Shares issuable upon the exchange of such Series B-1 Preferred Stock increased by an
aggregate of 74,674 and 14,659, respectively.
The shares of Series A Preferred Stock held by Organics and OHIF II LP are currently exchangeable into an
aggregate of 10,581,760 and 2,051,669, respectively, of Common Shares. Subject to the Series B-1 Exchange Caps, the shares of Series B-1 Preferred Stock held by Organics
and OHIF II LP are currently exchangeable into an aggregate of 5,090,082 and 999,251, respectively, of Common Shares.
Organics directly holds 17,315, 894
Common Shares representing approximately 17.3% of the issued and outstanding Common Shares (in each case, assuming the exchange of Series A Preferred Shares held by it into 10,581,760 shares of Common Shares), and has the sole power to vote and
dispose of such Common Shares. This amount assumes no shares of Series B-1 Preferred Stock may currently be exchanged for Common Shares as a result of one or more of the Series
B-1 Exchange Caps to which the Oaktree Funds are subject, as described more fully in Item 5 and Item 6 of Amendment No. 5 to this Schedule 13D.
OHIF II LP directly holds 3,410,234 Common Shares representing approximately 3.7% of the issued and outstanding Common Shares (in each case, assuming the
exchange of Series A Preferred Stock held by it into 2,051,669 shares of Common Shares), and has the sole power to vote and dispose of such Common Shares. This amount assumes no shares of Series B-1 Preferred
Stock may currently be exchanged for Common Shares as a result of one of more of the Series B-1 Exchange Caps to which the Oaktree Funds are subject, as described more fully in Item 5 and Item 6 of Amendment
No. 5 to this Schedule 13D.